$65.81
+1.97 (+3.09%)
Performance
1D
—
1W
—
1M
—
3M
+65.19%
6M
+68.40%
1Y
+147.97%
YTD
+57.48%
Open$64.67
Previous Close$63.84
Day High$66.62
Day Low$64.21
52W High$57.88
52W Low$14.80
Volume—
Avg Volume786.2K
Market Cap4.55B
P/E Ratio—
EPS$-2.03
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$47.74
Above
SMA 200
$36.07
Above
RSI (14)
57.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
-45.4% upside
Current
$65.81
$65.81
Target
$35.94
$35.94
$23.54
$35.94 avg
$41.91
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.64M | 3.43M | 1.61B |
| Net Income | -127,308,493 | -239,151,834 | -285,460,132 |
| Profit Margin | -7,729.5% | -7,343.0% | -17.7% |
| EBITDA | -165,762,219 | -328,687,347 | -344,556,820 |
| Free Cash Flow | — | — | -296,727,069 |
| Rev Growth | -52.1% | -52.1% | +15.2% |
| Debt/Equity | — | — | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |